Award-winning out-sourced drug discovery & development platform, offering a cutting-edge technology toolkit and comprehensive suite of services under one roof.
The Cambridge Partnership is the UK’s only specialist provider of finance, company secretarial and administrative services dedicated to biotech. Their flexible support helps founders focus on advancing science and creating value:
https://t.co/UTfpLwDpls
The RxCelerate team is at #BioTrinity this week.
Find us at Booth 15 to discuss how we can support your drug discovery journey - from in silico design to in vivo models, our expertise spans every stage of drug discovery and development.
Campus-based RxCelerate has launched RxPlorer™ - a new technology for finding small molecule hits, particularly against challenging, previously undruggable targets.
Full story
https://t.co/vYksPwjtYh
RxPlorer™ is our new metastate discovery platform, designed for rapid screening against undruggable targets.
Leveraging advanced molecular dynamics, RxPlorer™ uncovers protein metastates and reveals novel binding sites in difficult to target proteins:
https://t.co/Xk9OMjJyCl
We are pleased to share that we have been nominated for 3 awards this year:
🏆 Life Science Company of the Year
🏆 Biotech Company of the Year
🏆 Employer of the Year
These nominations recognise the strength of our science and the talented people who deliver it every day.
The finalists for the Cambridge Independent Science and Technology Awards 2026 can now be revealed
Congratulations to you all!
#SciTechAwards
https://t.co/pbXCt5GUNl
We're finalists for 'Best Performing R&D Services Company' @OneNucleus Awards 2026!
Following our win in 2025, this reinforces our position as a trusted partner for delivering high-quality science that efficiently progresses our clients programmes.
🔗https://t.co/NLoCpV4ag7
RxCelerate and Constructive Bio Announce Partnership to Advance Next-Generation Therapeutics
@BioConstructiv's pioneering programmable biology platform combined with our expert drug design & development capabilities to transform biologic drug development
https://t.co/dQRaVrlIgK
Find us at Booth C170 at #BIOEurope today!
Our tailored approach to drug discovery and development means we can efficiently and successfully advance your assets - by leveraging our proprietary technologies, in-house expertise and state of the art facilities.
It’s been great connecting with peers @ELRIG_SCIENCE
Visit Stand F13 to find out how our flexible, science-led approach can support your next programme
Or visit our posters no's 252 & 283, highlighting recent innovations from our in silico and preclinical teams #ELRIGDD25
Day 1 of #CamMedChem25 is underway!
Find out how our extensive experience designing and delivering bespoke small molecule discovery programmes can accelerate your timeline-without shortcuts or compromise-just a focus on the right science.
Meet Andy and Andrew at Booth 17.
We're a finalist for ‘Most Impactful CRO of the Year’ at @OBN_UK's Awards
Thank you for this recognition - named alongside many outstanding companies driving innovation across life sciences to improve patient outcomes.
The finalists 👉https://t.co/iYwgZwLimh
We’re finalists in the @CambridgeIndy Business Awards!
We are proud to be shortlisted for Employer of the Year. It reflects the incredible effort so many people across the business put into making RxCelerate a supportive and rewarding place to work.
🔗https://t.co/xHNA7IzNoL
We've been shortlisted in the 2025 @businessweekly Awards!
Thrilled to be recognised alongside some exceptional companies driving innovation across the Cambridge ecosystem. Congratulations to all those nominated.
Read more: https://t.co/aISqrWC9z0
#BusinessWeeklyAwards
We’re pleased to share a testimonial from @ValentBioSci, based in the US, following their successful use of our proprietary protein engineering technology.
It is great to see our collaborative approach and expertise delivering results for our clients.
🔗https://t.co/AjAkow8cox
Our CEO Jill is attending #ABI25 in Cambridge MA this week.
The invite-only event brings together leaders from across #lifesciences to share ideas and create new partnerships.
Find Jill to learn more about how RxCelerate supports innovative #drugdiscovery programmes.
A great week so far at #BIO2025 in #Boston
Interesting conversations, new connections and a real buzz around the UK Pavilion!
Meet us there (Stand 765) to talk about accelerating your drug discovery and development plans.
Connect via the partnering app or [email protected]
We're exhibiting on the UK Pavilion (Hall A, Stand 765) at #BIO2025.
Use the BIO Business Partnering System to book a meeting with us if you need #outsourced drug discovery & development support.
#BIO2025 is just around the corner and the UK’s most innovative #biotech companies and organizations will be there 🧬🧫
🗓️June 16-19
📍415 Summer Street Boston, MA
UK Pavilion, Hall A, Stand 765
Book an appointment today to meet them 👇https://t.co/6nw88DkkOq
Meet our chemists at #ANMC2025 this week, sharing how our small molecule drug design and development approach can add significant value to your programme.
Visit Booth 13 or contact: [email protected]
The RxCelerate team will be exhibiting and speaking at some exciting conferences, symposiums and events in June. Take a look at some of the places we’ll be, and get in touch to arrange to meet: [email protected].
https://t.co/NB0t3CnpHF
🗓️10 – 13 June: RSC BMCS Anglo-Nordic Medicinal Chemistry Symposium, 📍Snekkersten, Denmark #ANMC2025
🗓️16 – 19 June: UK Pavilion, BIO International Convention, 📍Boston, MA #BIO2025
🗓️19 June: #BioBabraham Symposium on Babraham Research Campus, 📍Cambridge, UK